Hemoglobinuria, Paroxysmal
Showing 1 - 25 of 775
Paroxysmal Nocturnal Hemoglobinuria Trial (Pozelimab, Cemdisiran)
Available
- Paroxysmal Nocturnal Hemoglobinuria
- (no location specified)
Aug 31, 2023
Paroxysmal Nocturnal Hemoglobinuria Trial (HRS-5965 tablets)
Not yet recruiting
- Paroxysmal Nocturnal Hemoglobinuria
- HRS-5965 tablets
- (no location specified)
Sep 20, 2023
Paroxysmal Nocturnal Hemoglobinuria Trial in Kyiv (OMS906 study drug)
Recruiting
- Paroxysmal Nocturnal Hemoglobinuria
- OMS906 study drug
-
Kyiv, UkraineOmeros Investigational Site
May 25, 2023
Paroxysmal Nocturnal Hemoglobinuria Trial in Bloemfontein, Cape Town, Pretoria (BCX10013)
Recruiting
- Paroxysmal Nocturnal Hemoglobinuria
-
Bloemfontein, South Africa
- +2 more
Oct 20, 2023
Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial (MY008211A tablets)
Not yet recruiting
- Paroxysmal Nocturnal Hemoglobinuria (PNH)
- MY008211A tablets
- (no location specified)
Nov 17, 2023
Pegcetacoplan in Paroxysmal Nocturnal Hemoglobinuria (PNH)
Not yet recruiting
- Paroxysmal Nocturnal Hemoglobinuria
- (no location specified)
Mar 17, 2023
PNH - Paroxysmal Nocturnal Hemoglobinuria Trial (NM8074)
Not yet recruiting
- PNH - Paroxysmal Nocturnal Hemoglobinuria
- (no location specified)
Feb 13, 2023
Paroxysmal Nocturnal Hemoglobinuria Trial in Tianjin (MY008211A tablets)
Recruiting
- Paroxysmal Nocturnal Hemoglobinuria
- MY008211A tablets
-
Tianjin, Tianjin, ChinaNstitute of Hematology & Blood Disease Hospital, Chinese Academy
Sep 17, 2023
Paroxysmal Nocturnal Hemoglobinuria Trial run by the Aplastic Anemia and MDS International Foundation
Recruiting
- Paroxysmal Nocturnal Hemoglobinuria
-
Bethesda, MarylandAplastic Anemia and MDS International Foundation
Feb 23, 2023
Paroxysmal Nocturnal Hemoglobinuria Trial in China (Eculizumab)
Not yet recruiting
- Paroxysmal Nocturnal Hemoglobinuria
-
Beijing, China
- +6 more
May 24, 2023
Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial in Brisbane (ADX-038, Placebo)
Not yet recruiting
- Paroxysmal Nocturnal Hemoglobinuria (PNH)
- ADX-038
- Placebo
-
Brisbane, Queensland, AustraliaNucleus Network Brisbane
May 17, 2023
Paroxysmal Nocturnal Hemoglobinuria Treated With Anti-C5
Completed
- Paroxysmal Nocturnal Hemoglobinuria
- Anti-C5 antibody treatment
-
Paris, FranceAP-HP Hôpital Saint Louis
Apr 24, 2023
Paroxysmal Nocturnal Hemoglobinuria Trial (Pozelimab, Cemdisiran)
Not yet recruiting
- Paroxysmal Nocturnal Hemoglobinuria
- (no location specified)
Feb 22, 2023
Paroxysmal Nocturnal Hemoglobinuria Trial in Worldwide (OMS906 Study Drug - 3 mg/kg, OMS906 Study Drug - 5 mg/kg, Ravulizumab)
Recruiting
- Paroxysmal Nocturnal Hemoglobinuria
- OMS906 Study Drug - 3 mg/kg
- +2 more
-
Aachen, Germany
- +4 more
Jul 25, 2023
Pharmacodynamics of Eculizumab in Paroxysmal Nocturnal
Completed
- Paroxysmal Nocturnal Hemoglobinuria
- +2 more
- Blood collection for measurement of eculizumab peak concentrations
-
Nijmegen, NetherlandsRadboudumc
Aug 23, 2022
Adult Paroxysmal Nocturnal Hemoglobinuria of High-risk Hemolysis
Completed
- Paroxysmal Nocturnal Hemoglobinuria, Natural History Study
-
Beijing, ChinaPeking Union Medical College Hospital
Jun 30, 2022
Paroxysmal Nocturnal Hemoglobinuria Trial (Iptacopan)
Not yet recruiting
- Paroxysmal Nocturnal Hemoglobinuria
- (no location specified)
Nov 18, 2022
Paroxysmal Nocturnal Hemoglobinuria Trial in Changsha (MY008211A tablets)
Completed
- Paroxysmal Nocturnal Hemoglobinuria
- MY008211A tablets
-
Changsha, Hunan, ChinaThe Third Hospital of Changsha
Apr 13, 2023
Paroxysmal Nocturnal Hemoglobinuria in ESUS & ETUS
Recruiting
- Paroxysmal Nocturnal Hemoglobinuria
- +3 more
-
London, Ontario, CanadaLondon Health Sciences Centre
May 10, 2022
Paroxysmal Nocturnal Hemoglobinuria Trial in Worldwide (Ravulizumab)
Active, not recruiting
- Paroxysmal Nocturnal Hemoglobinuria
- Ravulizumab
-
Atlanta, Georgia
- +8 more
Aug 15, 2022